The EPS projection of Carter's, Inc. (NYSE:CRI) for quarter ended 2016-09-30 is $1.79. Last week, the EPS forecast was $1.79 against target of $1.79, a month earlier. Two months ago, this estimate was $1.79 versus forecast of $1.79 three months earlier, implying a deviation of 0%.
Carter's, Inc. (NYSE:CRI) stated that 18 days ago, its stock price was positively revised 2 times while negative revisions were 1.
In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 4, 1, and 4, correspondingly.
EPS estimate downgrade for Carter's, Inc. (NYSE:CRI) in the preceding 30, 120, 60 and 90 days were 0, 0, 0, and 0, correspondingly.
Carter's, Inc. (NYSE:CRI) EPS target for the quarter closed 1 was $1.79, based on 5 recommendations. As reported on 2016-04-28 the EPS was $1.05. The change was $0.06, implying a percentage deviation of 6.06%. The projections showed a standard deviation of 0.02.
Quarterly Sales Estimates
Carter's, Inc. (NYSE:CRI) yearly sales prediction for the fiscal 2016 stands at $936.166 and the median estimate is at $928. Almost 3 analysts issued sales target.
Highest sales target is $953.3 while the lowest target is $927.2 showing standard deviation of 14.843%.
As many as 3 analysts have sales targets revised upside while 3 reduced sales estimates, implying a deviation of 0%.
Last month, 3 revised sales number projection on upside while 3 lowered the sales projections, implying a deviation of 0.146%.
A quarter ago, 3 hiked sales target and 3 reduced sales forecast. Carter's, Inc. (NYSE:CRI) announced that the deviation in forecast was 0.183%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...